Sign in

CIK 0001478320

  • Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
270907024
Phone
+1 206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Conversion Director acquired 2,217,101 shares (conversion)
  2. 4 Open-market sale Chief Scientific Officer sold 11,100 shares at an average $28.77 ($319,329)
  3. 4 Open-market sale SVP and General Counsel sold 662 shares at $30.00 ($19,860)
  4. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $29.87 ($597,400)
  5. 3 Insider Initial Statement of Ownership
  6. 4/A Open-market sale Director sold 5,000 shares at $30.00 ($150,000)
  7. 5 Insider Annual Insider Trading Report
  8. 4 Open-market sale SVP, Operations sold 60,000 shares at $29.14 ($1,748,400)
  9. 4/A Open-market sale Director sold 15,000 shares at an average $29.29 ($439,351)
  10. 4 Returned to the company Director returned 5,000 shares (to the company)
  11. 4 Open-market sale President sold 40,000 shares at $30.00 ($1,200,000)
  12. 4 Open-market sale President sold 135,000 shares at an average $28.98 ($3,912,585)
  13. 4 Returned to the company Director returned 15,000 shares (to the company)
  14. 4 Open-market sale President sold 160,000 shares at an average $29.73 ($4,757,060)
  15. 4 Exercise or conversion CEO and Chairman acquired 20,000 shares (option exercise)
  16. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $20.00 ($20,000)
  17. 4 Open-market buy Sr Vice President, Operations bought 11,200 shares at $20.00 ($224,000)
  18. 4 Conversion Director acquired 3,866,016 shares (conversion)
  19. 4 Conversion CEO and Chairman acquired 70,680 shares (conversion)
  20. 4 Conversion Chief Scientific Officer acquired 70,679 shares (conversion)

Page 26 of 28 · 544 filings